Back to VRTX

VERTEX PHARMACEUTICALS INC / MA Long-Term Debt 2011-2011 | VRTX

Beta
No annual data available.
Long-Term Debt History
PeriodValueSource
Q3 FY2011$105.0M+0.0%10-Q
Q2 FY2011$105.0M+0.0%10-Q
Q1 FY2011$105.0M-10-Q
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →